HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01659

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 260 to 279 of 545 < previous next >

Title	Author(s)	Issue Date	Views
Lamivudine therapy for chronic hepatitis B Journal:The Annals of Gastroenterology & Hepatology	Seto, WK Lai, CL Fung, J Yuen, RMF	2010	22
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance Journal:Hepatology	Seto, WK Wong, DKH Fung, J Hung, IFN Fong, DYT Yuen, JCH Tong, T Lai, CL Yuen, MF	2012	191
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B Journal:PLoS ONE	Seto, WK Lai, CL Ip, PPC Fung, J Wong, DKH Yuen, JCH Hung, IFN Yuen, MF	2012	189
Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement” Journal:Journal of Hepatology	Mak, LY Yuen, MF Seto, WK	2020	21
Letter: is body-mass index really associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B? Authors' reply Journal:Alimentary Pharmacology and Therapeutics	Seto, WKW Yuen, RMF	2017	47
Level of hepatitis B surface antigen and not HBV DNA level after HBeAg seroclearance is predictive of HBsAg seroclearance Proceeding/Conference:Journal of Hepatology	Fung, JYY Lai, CL Wong, DKH Seto, WKW Kopaniszen, M Yuen, RMF	2014	86
Levels of HBV DNA and not HBsAg are associated with biochemical flares after HBeAg seroconversion Proceeding/Conference:Hepatology International	Fung, J Lai, CL Seto, WK Wong, DKH Yuen, MF	2012	126
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B Journal:Clinical Microbiology and Infection	Seto, WKW Wong, DKH Fung, JYY Huang, FY Liu, KS Lai, CL Yuen, RMF	2014	81
Liver fibrosis burden determines risk of hepatocellular carcinoma among patients with hepatitis B surface antigen seroclearance. Poster Presentation (THU360) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Mak, LY Cheung, KSM Hui, WHR Wong, DKH Fung, JYY Yuen, RMF Seto, WKW	2022
Liver fibrosis burden determines risk of hepatocellular carcinoma among patients with hepatitis B surface antigen seroclearance Proceeding/Conference:The International Liver Congress 2022	Mak, LY Cheung, KSM Hui, WHR Wong, DKH Fung, J Yuen, RMF Seto, WKW	2022
Liver stiffness and histological features in healthy persons, and patients with occult hepatitis B, chronic active hepatitis B, and hepatitis B-related cirrhosis. Proceeding/Conference:Hepatology	Fung, JYY Lai, CL Chan, SC But, D Seto, WKW Cheng, CTK Wong, DKH Lo, CM Fan, ST Yuen, RMF	2009	30
Liver toxicity from traditional Chinese medication: a diagnostic challenge Proceeding/Conference:Hospital Authority Convention, HAC 2016	Seto, WKW	2016	21
Long term nucleos(t)ide analogue therapy reduced the extent of HBV DNA integration in chronic hepatitis B patients Proceeding/Conference:Hepatology	Chow, N Wong, DKH Mak, LY Fung, JYY Seto, WKW Lai, CL Yuen, RMF	2020	30
Long-term aspirin and risk of gastric cancer after H. pylori eradication: a population-based study with propensity score analysis Proceeding/Conference:United European Gastroenterology Journal	Cheung, KSM Wong, AYS Chan, EWY Chen, L Seto, WKW Wong, ICK Leung, WK	2017	20
Long-term follow-up of biliary atresia using liver transient elastography Journal:Pediatric Surgery International	Yeung, F Fung, ACH Chung, HY Chu, YYS Seto, WKW Wong, KKY	2022	12
Long-term follow-up of biliary atresia using liver transient elastography Journal:Pediatric Surgery International	Yeung, Fanny Fung, Adrian C.H.Chung, Patrick H.Y.Chu, Y. Y.Seto, W. K.Wong, Kenneth K.Y.	2022
Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B Journal:Gut and Liver	Hui, KY Fung, J Cheung, KSM Mak, LY Seto, WKW Yuen, RMF	2022
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease Journal:Antiviral Therapy	Yuen, MF Seto, WK Chow, DHF Tsui, K Wong, DKH Ngai, VWS Wong, BCY Fung, J Yuen, JCH Lai, CL	2007	112
Long-term outcome of hepatitis B e-antigen seroclearance in chronic hepatitis B - results from the C.H.E.S.S. cohort Proceeding/Conference:Journal of Hepatology	Fung, JYY Seto, WKW Wong, DKH Lai, CL Yuen, RMF	2016	40
Long-term outcomes and significance of HBeAg Seroclearance in Chronic Hepatitis B: Novel Predictive Scores for HCC and HBsAg seroclearance Proceeding/Conference:Journal of Hepatology	Fung, JYY Cheung, KSM Wong, DKH Mak, LY To, WP Seto, WKW Lai, CL Yuen, RMF	2018	65

Showing results 260 to 279 of 545 < previous next >